BackCinCor Pharma Overview

CinCor Pharma Total Liabilities

Latest total liabilities for CINC: $10M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$10.18M
↓ 94.70% YoYΔ $-181.89M vs prior year quarter

Peer average

Loading

CinCor Pharma Total Liabilities History

Loading

CinCor Pharma vs. peers: Total Liabilities Comparison

Loading

CinCor Pharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CinCor Pharma (CINC) FAQ

CinCor Pharma (CINC) currently reports a total liabilities of $10M as of September 2022. That compares with $190M in the prior-year period — down 94.7% year over year. Use the charts on this page to explore CinCor Pharma's total liabilities history and peer comparisons.

CinCor Pharma's total liabilities decreased from $190M to $10M — a 94.7% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CinCor Pharma reported $10M in total liabilities as of September 2022. That compares with $190M in the prior-year period — down 94.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CinCor Pharma, and consider following CINC for alerts when major investors trade the stock.